Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Intratympanic therapy in Meniere?s syndrome or disease: Up to date evidence for clinical practice

2nd International Conference and Exhibition on Rhinology and Otology

Mohammed Iqbal Syed

ScientificTracks Abstracts: Otolaryngol (Sunnyvale)

DOI: 10.4172/2161-119X.S1.007

Abstract
Background: Meniere?s syndrome or disease (MS/D) is typically characterized by episodic vertigo, aural fullness, tinnitus and fluctuating hearing loss. There are multiple options available for treatment with variation in consensus on the best intervention. Objective: To evaluate the evidence on the efficacy of intratympanic therapies [steroids, gentamicin, antiviral therapy and other therapies] on the frequency and severity of vertigo and other symptoms of MS/D Search strategy: A literature search was performed on amed, embase, hmic, medline, psycinfo, bni, cinahl, health business elite, central and Cochrane Ear, Nose and Throat disorders group trials register using various MeSH. The search was restricted to English and human subjects and the last date of search was Dec 2014 Selection Criteria: Randomized controlled trials of intratympanic therapies [steroids, gentamicin and antiviral agents, latanoprost] versus a placebo or another treatment. Results: 8 RCT?s were analyzed comparing intratympanic steroids, gentamicin, Ganciclovir (antiviral) and latanoprost versus another form of intratympanic treatment or placebo. Conclusions: On the basis of 6 RCT?s (n=242) there is evidence to support the effectiveness of intratympanic steroids and gentamicin to control symptoms of vertigo in MS/D albeit with a risk of hearing loss in gentamicin. However, there was no consensus found on doses or treatment protocols. There was no evidence for the use of other forms of intratympanic therapy (antivirals and latanoprost) in MS/D
Biography
Mohammed Iqbal Syed completed his MBBS and a Master?s degree in Otolaryngology from the Pune University in India. He completed his specialist training (DLO and FRCS) from the United Kingdom and was awarded a travelling fellowship to the University Hospital in Zurich and the TWJ clinical fellowship in Otology/Skull base surgery at the University of Toronto. He has published over 25 peer reviewed papers and presently is a Consultant in Otology and Skull base surgery at the Royal Infirmary/Western Infirmary in Edinburgh.
Top